Texas Oncology- Northeast Texas is a clinical research site located in Tyler, Texas, United States 75702.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology- Northeast Texas has participated in 9 clinical trials with 6 currently active.
Therapeutic areas: Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Carcinoma, Non-Small-Cell Lung, HER2-Positive Early Breast Cancer.
Sponsors: Stingray Therapeutics, US Oncology Research, Hoffmann-La Roche.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology- Northeast Texas has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology- Northeast Texas has 9 clinical trials on record, with 6 currently active. Their work covers Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Carcinoma, Non-Small-Cell Lung, HER2-Positive Early Breast Cancer.
Yes — Texas Oncology- Northeast Texas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.